STOCK TITAN
  1. Home
  2. News
  3. SLGC

Somalogic, Inc. - SLGC STOCK NEWS

Welcome to our dedicated page for Somalogic news (Ticker: SLGC), a resource for investors and traders seeking the latest updates and insights on Somalogic stock.

SomaLogic, Inc. (Nasdaq: SLGC) delivers cutting-edge proteomics solutions to advance disease research and diagnostic capabilities. This dedicated news center provides stakeholders with timely updates on strategic developments, financial milestones, and technological breakthroughs shaping the future of healthcare innovation.

Investors and industry professionals will find authoritative coverage of SLGC's proposed merger with Standard BioTools, quarterly earnings reports, and collaborations driving precision medicine. Our repository includes verified press releases on platform enhancements, clinical study outcomes, and executive leadership decisions.

Key focus areas span oncology, metabolic disease research, and large-scale proteomic data applications. Bookmark this page for streamlined access to SomaLogic's latest regulatory filings, partnership announcements, and peer-reviewed scientific achievements. Visit regularly to stay informed about developments impacting the diagnostics and life sciences sectors.

News

OncoHost Selected to Present in Oral Minisymposium at American Association of Cancer Research (AACR) Annual Meeting 2024

Rhea-AI Summary
OncoHost to present new results at AACR Annual Meeting showcasing PROphet® platform's machine learning models for predicting therapeutic benefit and immune-related adverse events in NSCLC patients treated with immunotherapy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
News

SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting

Rhea-AI Summary
SomaLogic, Inc. (Nasdaq: SLGC) announced stockholder approval for the transaction with Standard BioTools Inc. (Nasdaq: LAB), creating a diversified leader in life sciences tools. The merger is expected to close on January 5, 2024, subject to certain closing conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News

Madryn Asset Management Demands SomaLogic’s Board Address Repeated, Unprecedented Adjournments of Tainted Special Meeting

Rhea-AI Summary
Madryn Asset Management, LP (Madryn) demands SomaLogic, Inc. (Nasdaq: SLGC) to answer key questions related to the repeated adjournments of the Special Meeting of Shareholders pertaining to the proposed merger with Standard BioTools Inc. (Nasdaq: LAB). Madryn believes the Board of Directors have betrayed shareholders by delaying the Special Meeting five times for a covert vote-flipping campaign. Madryn has sent a litigation hold to the SomaLogic Board and urges shareholders interested in changing their vote to contact Madryn or the firm’s proxy solicitor.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News

Madryn Asset Management Addresses SomaLogic’s Apparent Failure to Obtain Requisite Shareholder Support for the Proposed Merger with Standard BioTools

Rhea-AI Summary
SomaLogic, Inc. (SOMA) faces challenges as fellow shareholders express concerns over the deal consideration and the company's cash assets, leading to last-minute adjournments of a special meeting.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
acquisition
-
News

SomaLogic Urges Stockholders to Maximize Value of Their Investment by Voting "FOR" Pending Merger with Standard BioTools

Rhea-AI Summary
SomaLogic, Inc. (Nasdaq: SLGC) is urged by leading proxy advisory firms ISS and Glass Lewis to vote 'FOR' the proposed merger with Standard BioTools. The merger is expected to accelerate profitability and value creation, bringing in over $180 million of pro-forma combined revenue, over $500 million of cash, and only $68 million of debt, with $80 million in anticipated cost synergies achieved by 2026.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.16%
Tags
acquisition
-
News

Boston Millennia Partners Intends to Vote Against Proposed Merger of SomaLogic With Standard BioTools

Rhea-AI Summary
Boston Millennia Partners (Nasdaq: BMP) opposes SomaLogic's (Nasdaq: SLGC) merger with Standard BioTools Inc.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
acquisition
News

Madryn Asset Management Highlights Increasing Public Shareholder Opposition to Value-Destructive SomaLogic Merger and Calls on Company to Make Additional Disclosures

Rhea-AI Summary
Madryn Asset Management, LP (Madryn) urges shareholders to vote 'AGAINST' the proposed merger between SomaLogic, Inc. (SLGC) and Standard BioTools Inc. (LAB). Four significant shareholders, including the company founder, have openly stated their opposition to the merger, highlighting concerns about undervaluation and a flawed process. The recommendation from proxy advisory service ISS only offered 'cautionary support' for the merger, leaving room for shareholders to vote 'AGAINST' the transaction.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
acquisition
-
News

SomaLogic Board Reiterates Value-Maximizing Transaction with Standard BioTools is in Best Interests of All Stockholders

Rhea-AI Summary
SomaLogic, Inc. (Nasdaq: SLGC) continues to recommend stockholders vote 'FOR' the pending merger with Standard BioTools, emphasizing the benefits of the transaction for all stockholders and the company's future potential.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.89%
Tags
none
-
News

Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic's Proposed Merger with Standard BioTools

Rhea-AI Summary
SomaLogic, Inc. (Nasdaq: SLGC) founders Dr. Larry Gold and Dr. Jason Cleveland express opposition to the proposed merger with Standard BioTools, Inc. (Nasdaq: LAB) in a letter to stockholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
acquisition
News

SomaLogic Issues Statement Correcting Madryn Asset Management's Misleading Disclosure

Rhea-AI Summary
SomaLogic, Inc. (Nasdaq: SLGC) responds to Madryn Asset Management's misleading press release regarding the pending merger with Standard BioTools (Nasdaq: LAB).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Stock SLGC logo
Somalogic, Inc.

Nasdaq:SLGC

SLGC Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

SLGC Stock Data

396.23M
175.53M
2.16%
61.71%
3.79%
Health Information Services
Healthcare
Link
United States
Boulder